TLR4 and hepatocellular carcinoma: TCGA-LIHC survival analysis has found that low expression of TLR4 is unfavorable for the survival of HCC patients, which is consistent with the high level of expression of pir-hsa-216911 in the HCC cell line upon inhibition of TLR4 as expected (Fig. 5D).